Case report
Subtrochanteric stress fracture of the femur following total knee arthroplasty

https://doi.org/10.1016/S0883-5403(97)90184-4Get rights and content

Abstract

This study reports the first case of a subtrochanteric stress fracture of the femur after total knee arthroplasty. A 61-year-old obese woman was treated by right total knee arthroplasty for osteoarthrosis. Four months after the surgery and 1 month after full weight bearing, she complained of tenderness in the right groin and proximal thigh. There was no history of trauma. Radiographs of the right hip and of the right proximal femur were interpreted as unremarkable, and nonsteroid anti-inflammatory drugs were administered. Three months later, she had a sudden onset of increased pain with instability and giving way of the right leg. Radiographs revealed a subtrochanteric transverse fracture of the right femur. Histologic workup of the bone and tissue specimen taken at open reduction, as well as the laboratory data were consistent with the radiologic and clinical diagnosis of a stress fracture. It is most likely that a decrease in the tension band effect of the iliotibial tract in combination with coxa vara and changes in static and dynamic forces of the femur and an increased level of activity after a period of relative inactivity secondary to the knee arthroplasty are responsible for this very uncommon fracture type.

References (17)

There are more references available in the full text version of this article.

Cited by (29)

  • Calcaneal insufficiency fractures following ipsilateral total knee arthroplasty

    2021, Injury
    Citation Excerpt :

    The P value was also smaller in HKA (P = 0.001). Previous case reports have described IFs following TKA, including those of the femur [9–17], fibula [18,19], tibia [20–22], metatarsal bone [23,24], pubis [25], and calcaneus [1–8]. However, there are only few study reports published in English, describing calcaneal IFs following TKA, and no cases have been reported from any country other than Japan or South Korea.

  • Bisphosphonate therapy for osteoporosis: Benefits, risks, and drug holiday

    2013, American Journal of Medicine
    Citation Excerpt :

    Glucocorticoids and proton-pump inhibitor therapy have been identified as risk factors for atypical fractures in some,39 but not all,40,41 studies. Atypical femoral fractures also occur in bisphosphonate-naïve patients.41-46 Sparse information is available about the incidence of atypical femoral fractures in patients with and without bisphosphonate treatment.

  • Antiresorptive drugs (bisphosphonates), atypical fractures and rebound effect: New evidence of similitude

    2012, Homeopathy
    Citation Excerpt :

    Clinical features include prodromal pain for weeks to months prior to the fracture,38-41 lack of precipitating trauma,38-41 bilaterality (either simultaneous or sequential),38,39,42,43 poor fracture healing,38,44 and normal or low bone mass but not osteoporosis in the hip region.42,45,46 Radiographic features that appear distinctive include presence of stress reaction (focal uptake on bone) on the affected and/or unaffected side,38–40,43,47 transverse or short oblique fractures40 (in contrast to the more common osteoporosis-related spiral or longitudinal fracture) and cortical hypertrophy or thickening.38 According to the wide analysis of the ASBMR Task Force26 the total number of reported cases of atypical ST/FS fractures was 310 after overlapping case reports had been excluded (286 cases occurred in association with BP treatment for osteoporosis and 5 associated with malignancy).

  • Femoral Fractures in Osteoporotic Patients on Bisphosphnates. A Case Report

    2012, Journal of Clinical Densitometry
    Citation Excerpt :

    These include lack of precipitating trauma (11,13,37); bilaterality (either simultaneous or sequential) (11–13,16); transverse fractures (37); increased cortical thickness (11), stress reaction on the affected and/or unaffected side (11,13,15,16,37); and/or poor fracture healing (11,38). Other clinical features include prodromal pain in thigh or groin for weeks or months before the fracture (11,13,37); use of an additional antiresorptive agent (estrogen, raloxifene, and calcitonin); use of glucocorticoids or proton pump inhibitor in addition to BPs (11,12,15); presence of rheumatoid arthritis or diabetes mellitus; serum (25(OH)D) levels less than 20 ng/mL; and normal or low BMD but not osteoporosis in the hip region (12,25,35). Earlier detection before clinical fracture in this case would have been helpful.

View all citing articles on Scopus
View full text